Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595387 · ClinicalTrials.gov registry record · NA
Effectiveness of Cognitive Behavioral Therapy for Treating Depression in People With Bipolar I Disorder
A NA study of Depression and Bipolar Disorder, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT00595387: Completed NA study of Depression and Bipolar Disorder, sponsored by Massachusetts General Hospital.
NCT00595387 is a NA study of Depression and Bipolar Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 54 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00595387, a NA study of Depression and Bipolar Disorder, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the effectiveness of cognitive behavioral therapy versus supportive psychotherapy in decreasing depression in people with bipolar disorder.
Conditions Studied
Interventions
- OTHER Supportive Psychotherapy
- OTHER Cognitive Behavioral Therapy (CBT)
Study Locations (1)
Massachusetts
- Massachusetts General Hospital Bipolar Clinic and Research Program - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2006-09 |
| Est. Completion | 2013-01 |
| Phase | NA |
What the finished NCT00595387 record still lists
NCT00595387 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Supportive Psychotherapy is the first listed.
NCT00595387 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00595387 about?
NCT00595387 is a clinical study titled "Effectiveness of Cognitive Behavioral Therapy for Treating Depression in People With Bipolar I Disorder". This study will compare the effectiveness of cognitive behavioral therapy versus supportive psychotherapy in decreasing depression in people with bipolar disorder.
What is the current status of trial NCT00595387?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2006-09. Estimated completion is 2013-01.
What conditions does trial NCT00595387 study?
This clinical trial studies the following conditions: Depression, Bipolar Disorder.
What interventions are being tested in trial NCT00595387?
The interventions under investigation include: Supportive Psychotherapy (OTHER), Cognitive Behavioral Therapy (CBT) (OTHER).
Who is sponsoring clinical trial NCT00595387?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00595387 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00595387's enrollment target sits among peer trials
54 457th of 679 higher than 219 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia